LAA closure is evolving: are you ready?
Sponsored by Boston Scientific
LAA Closure
Symposium
Boston Scientific
Simulation Learning Room
Anchorperson: Jens Erik Nielsen-Kudsk
Spokesperson: John Camm
Discussants: Philippe Garot, Kasper Korsholm, Apostolos Tzikas
Watch this session if you want
- To recognise the unmet needs in stroke prevention for patients with atrial fibrillation, especially those at high bleeding risk or with inadequate protection under direct oral anticoagulants therapy
- To evaluate the risks of bleeding, stroke despite anticoagulation, and non-adherence in atrial fibrillation patients treated with NOACs
- To interpret the latest clinical evidence and guideline recommendations on left atrial appendage closure (LAA closure)
- To identify patient populations who may derive the greatest benefit from LAA closure
Welcome and session objectives
Jens Erik Nielsen-Kudsk
Unmet needs in stroke prevention
Discussion and audience interaction
Balancing efficacy and safety
Philippe Garot
Discussion and audience interaction
Why anticoagulation isn’t always enough
Kasper Korsholm
Discussion and audience interaction
From missed doses to missed opportunities
Apostolos Tzikas
Discussion and audience interaction
Guideline perspectives
Jens Erik Nielsen-Kudsk
Discussion and audience interaction
Session evaluation and key learnings
Jens Erik Nielsen-Kudsk
